文献速递甲状腺疾病

超声与CT均诊断为临床N0期甲状腺乳头状癌患者中具有临床意义的中央区淋巴结转移并不常见

Clinically Significant Central Lymph Node Metastasis is Not Common in Patients with Clinically N0 Papillary Thyroid Carcinoma on Both Ultrasonography and CT.
PubMed 文献 · Thyroid · 2025-03-31

该回顾性队列纳入2000年1月至2022年9月接受甲状腺切除术联合预防性中央区淋巴结清扫的3002例经超声和颈部CT评估为临床淋巴结阴性(cN0)的甲状腺乳头状癌患者,中位随访4.52年。结果显示39.7%存在中央区淋巴结转移,但80.5%为低危转移或无转移,仅2.5%为高危转移;无转移、低危转移和中/高危转移组的复发率分别为0.4%、1.1%和1.9%(p=0.012)。作者认为若术前超声和颈部CT均未见中央区淋巴结转移证据,预防性中央区淋巴结清扫可能不必要。

要点

  • cN0期PTC患者中,39.7%(1194/3002)存在中央区淋巴结转移,但80.5%为低危转移或无转移。
  • 高危转移仅占2.5%(77/3002),中/高危转移患者中98.8%(577/584)转移灶<1 cm。
  • 无转移、低危转移、中/高危转移组复发率分别为0.4%、1.1%、1.9%(p=0.012)。

核心结论

  • 经超声和CT评估为cN0的PTC患者中,中央区清扫后多数淋巴结为无转移或低危转移,且转移淋巴结多数<1 cm。
  • 作者认为若术前甲状腺超声和颈部CT均无中央区淋巴结转移证据,预防性中央区淋巴结清扫可能不必要。

研究设计与样本

  • 回顾性队列研究,纳入2000年1月至2022年9月接受甲状腺切除术联合预防性中央区淋巴结清扫的3002例经术前甲状腺超声和颈部CT评估为临床淋巴结阴性的PTC患者。
  • 临床淋巴结阴性定义为术前超声和颈部CT均无 suspicious 转移性淋巴结。
  • 低危中央区淋巴结转移定义为转移淋巴结<2 mm且转移淋巴结≤5枚。
  • 中位随访时间为4.52年(四分位距[IQR]:1.6-7.5年)。

主要发现

  • 3002例患者中,1194例(39.7%)存在中央区淋巴结转移,1808例(60.3%)无中央区淋巴结转移。
  • 1194例中央区淋巴结转移患者中,507例(16.9%)为中危转移,610例(20.3%)为低危转移;低危转移或无中央区淋巴结转移者共2428例(80.5%)。
  • 高危转移仅见于77例(2.5%)患者;584例中/高危转移患者中,577例(98.8%)中央区转移淋巴结<1 cm,仅7例(1.2%)≥1 cm。
  • 无淋巴结转移组、低危转移组和中/高危转移组的疾病复发率分别为0.4%、1.1%和1.9%(p=0.012)。
  • 与中/高危中央区淋巴结转移独立相关的因素包括年龄<55岁(OR=2.29)、男性(OR=2.33)、超声示肿瘤大小>1 cm(OR=1.94)以及CT示甲状腺外侵犯(OR=1.53),所有因素p<0.001。

关键数值与推荐

  • 低危中央区淋巴结转移定义为转移淋巴结<2 mm且转移淋巴结≤5枚。
  • 中/高危中央区淋巴结转移的独立相关因素:年龄<55岁(OR=2.29)、男性(OR=2.33)、超声示肿瘤大小>1 cm(OR=1.94)、CT示甲状腺外侵犯(OR=1.53),所有因素p<0.001。
  • 无转移、低危转移和中/高危转移组的复发率分别为0.4%、1.1%和1.9%(p=0.012)。

临床怎么用

  • 作者认为若术前甲状腺超声和颈部CT均无中央区淋巴结转移证据,预防性中央区淋巴结清扫可能不必要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The necessity of prophylactic central lymph node dissection (p-CLND) in patients with clinically node-negative papillary thyroid carcinoma (PTC) is unclear. The present study evaluated the central lymph node (LN) metastases status in patients with clinically node-negative PTC on both preoperative thyroid ultrasonography (USG) and neck computed tomography (CT) who underwent p-CLND. Methods: This retrospective cohort study included 3002 clinically node-negative patients diagnosed with PTC who had undergone thyroidectomy with p-CLND from January 2000 to September 2022. Clinically node-negative was defined as the absence of suspicious metastatic LNs on preoperative USG and neck CT. Low-risk central LN metastases were defined as LN metastases <2 mm in size with metastatic LNs ≤5. The median follow-up duration was 4.52 (interquartile range [IQR]: 1.6-7.5) years. Results: Of the 3002 patients, 1194 (39.7%) had central LN metastases, whereas 1808 (60.3%) did not. The 1194 patients with central LN metastases included 507 (16.9%) with intermediate-risk metastases and 610 (20.3%) with low-risk LN metastases, with a total of 2428 (80.5%) patients having low-risk LN metastases or no central LN metastases. High-risk metastases were observed in only 77 (2.5%) patients. Of the 584 patients with intermediate-/high-risk metastases, 577 (98.8%) had central LN metastases <1 cm in size, whereas only 7 (1.2%) had central LN metastases ≥1 cm. The disease recurrence rates for the no LN metastases, low-risk LN metastases, and intermediate-/high-risk LN metastases groups were 0.4%, 1.1%, and 1.9%, respectively (p = 0.012). Factors independently associated with intermediate-/high-risk central LN metastases included age <55 years (odds ratio [OR] = 2.29), male sex (OR = 2.33), tumor size >1 cm on USG (OR = 1.94), and the presence of extrathyroidal extension on CT scans (OR = 1.53), with p < 0.001 for all factors. Conclusions: Most LNs confirmed after CLND in cN0 PTC patients assessed by USG and CT were either metastasis-free or classified as low-risk metastatic LNs. Furthermore, the majority of metastatic LNs were small in size, typically measuring <1 cm. p-CLND may be unnecessary if preoperative thyroid USG and neck CT show no evidence of central neck LN metastaes.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Kim BC, Pak SJ, Kwon D, et al. Clinically Significant Central Lymph Node Metastasis is Not Common in Patients with Clinically N0 Papillary Thyroid Carcinoma on Both Ultrasonography and CT. Thyroid. 2025. PMID: 40160107. doi:10.1089/thy.2024.0484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。